Perturbation of the dimer interface of triosephosphate isomerase and its effect on Trypanosoma cruzi.
<h4>Background</h4>Chagas disease affects around 18 million people in the American continent. Unfortunately, there is no satisfactory treatment for the disease. The drugs currently used are not specific and exert serious toxic effects. Thus, there is an urgent need for drugs that are eff...
Guardado en:
Autores principales: | Vanesa Olivares-Illana, Adela Rodríguez-Romero, Ingeborg Becker, Miriam Berzunza, Juventino García, Ruy Pérez-Montfort, Nallely Cabrera, Francisco López-Calahorra, Marieta Tuena de Gómez-Puyou, Armando Gómez-Puyou |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2007
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2aeb4e994377455d9215a7851a76ceff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structural Analysis of an Epitope Candidate of Triosephosphate Isomerase in Opisthorchis viverrini
por: Jonghyeon Son, et al.
Publicado: (2018) -
Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation
por: B. Hernández-Ochoa, et al.
Publicado: (2017) -
Protein Profiles of Trypanosoma cruzi and Trypanosoma rangeli
por: MEJÍA,ASTRID J, et al.
Publicado: (2004) -
Natural reservoirs of Trypanosoma cruzi
Publicado: (2000) -
Triosephosphate Isomerase Is Dispensable <italic toggle="yes">In Vitro</italic> yet Essential for <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> To Establish Infection
por: Carolina Trujillo, et al.
Publicado: (2014)